BioMarin Pharmaceutical (BMRN) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

BMRN is expected to report earnings to fall 49.45% to 35 cents per share on July 30

BioMarin Pharmaceutical BMRN Stock Earnings Reports
Q2'24
Est.
$0.36
Q1'24
Beat
by $0.39
Q4'23
Beat
by $0.29
Q3'23
Beat
by $0.23
Q2'23
Beat
by $0.31
The last earnings report on April 24 showed earnings per share of 70 cents, beating the estimate of 31 cents. With 1.28M shares outstanding, the current market capitalization sits at 15.97B.
View a ticker or compare two or three
BMRN
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of innovative pharmaceuticals for serious diseases & medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3401
Web
https://www.biomarin.com